Evidence map›Paper›PMID 33288545›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2021

SLAMF7 Signaling Reprograms T Cells toward Exhaustion in the Tumor Microenvironment.

Patrick O'Connell, Sean Hyslop, Maja K Blake, Sarah Godbehere, Andrea Amalfitano, Yasser A Aldhamen

Open access · greenAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 65 papers.

0numbers the graph read from it
0cells of the map it votes in
65citing papers in PubMed
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

65 citing papers in PubMed, 102 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Exhausted CD4Frontiers in immunology · 2026
    Article
  6. Review
  7. Article
  8. Observational
  9. Article
  10. Article
  11. Observational
  12. Article
  13. Article
  14. Article
  15. Article
  16. SLAM family-mediated crosstalk between tumor and immune cells in the tumor microenvironment: a promising biomarker and a potential therapeutic target for immune checkpoint therapies.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2025
    Review
  17. SLAMF7 (CD319) on activated CD8Cell death and differentiation · 2025
    Article
  18. Article
  19. Article
  20. Article

5 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Patrick O'ConnellDepartment of Microbiology and Molecular Genetics, College of Osteopathic Medicine, Michigan State University, East Lansing, MI 48824; and.ORCID 0000-0001-7534-4754
Sean HyslopDepartment of Microbiology and Molecular Genetics, College of Osteopathic Medicine, Michigan State University, East Lansing, MI 48824; and.ORCID 0000-0002-6993-3795
Maja K BlakeDepartment of Microbiology and Molecular Genetics, College of Osteopathic Medicine, Michigan State University, East Lansing, MI 48824; and.
Sarah GodbehereDepartment of Microbiology and Molecular Genetics, College of Osteopathic Medicine, Michigan State University, East Lansing, MI 48824; and.
Andrea AmalfitanoDepartment of Microbiology and Molecular Genetics, College of Osteopathic Medicine, Michigan State University, East Lansing, MI 48824; and.ORCID 0000-0001-9480-1420
Yasser A AldhamenDepartment of Microbiology and Molecular Genetics, College of Osteopathic Medicine, Michigan State University, East Lansing, MI 48824; and aldhamen@msu.edu.
Michigan State University · US

Funding

Novel Immunomodulating Therapeutics for HIV-1 TreatmentR21AI122808 · NIAID · MICHIGAN STATE UNIVERSITY · PI ALDHAMEN, YASSER · 2016 to 2017
$410k
NIAID NIH HHS R21 AI122808
6 · The paper itself

Abstract

T cell exhaustion represents one of the most pervasive strategies tumors employ to circumvent the immune system. Although repetitive, cognate TCR signaling is recognized as the primary driving force behind this phenomenon, and it remains unknown what other forces drive T cell exhaustion in the tumor microenvironment (TME). In this study, we show that activation of the self-ligand SLAMF7 immune receptor on T cells induced STAT1 and STAT3 phosphorylation, expression of multiple inhibitory receptors, and transcription factors associated with T cell exhaustion. Analysis of The Cancer Genome Atlas revealed that SLAMF7 transcript levels were strongly correlated with various inhibitory receptors and that high SLAMF7 expression was indicative of poor survival in clear cell renal cell carcinoma (ccRCC). Targeted reanalysis of a CyTOF dataset, which profiled the TME in 73 ccRCC patients, revealed cell-type-specific SLAMF7 expression patterns, strong correlations between exhausted T cells and SLAMF7

Indexed as

AnimalsCarcinoma, Renal CellCells, CulturedCellular ReprogrammingFemaleGene Expression Regulation, NeoplasticHumansImmune ToleranceKidney NeoplasmsMaleMelanomaMelanoma, ExperimentalMiceMice, Inbred C57BLMice, KnockoutNeoplasms, ExperimentalSignaling Lymphocytic Activation Molecule FamilySLAMF7 protein, humanSlamf7 protein, mouse

Identifiers

PMID33288545
PMCPMC7855551
OpenAlexW3110715203

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.